Clinical Trials Directory

Trials / Unknown

UnknownNCT01138176

Whole Body Cooling Using Phase Changing Material

Phase II Randomized Control Trial of Whole Body Cooling in Neonatal Encephalopathy Using Phase Changing Material

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
35 (estimated)
Sponsor
Robertson, Nicola, M.D. · Individual
Sex
All
Age
24 Hours
Healthy volunteers
Not accepted

Summary

A prospective randomized control trial to examine safety and effectiveness of whole body cooling to a rectal temperature of 33.5 C using phase changing material in neonatal encephalopathy. Effectiveness will be defined by examining the stability of rectal temperature during cooling. Monitoring of vital signs, infection screen, blood counts, coagulation screen, liver and renal function tests, cranial US and MR imaging will be performed on recruited infants to evaluate safety of cooling. EEG will be performed on day 4 and hearing evaluation at discharge. Neurodevelopmental evaluation will be performed at 1 year of age.

Detailed description

Meta-analyses of these trials show that therapeutic hypothermia increases survival with normal neurological function (pooled risk ratio of 1.53) with a number needed to treat of 8 (95% confidence interval (CI) 5 - 17) and in survivors reduces the rates of severe disability and cerebral palsy. Therapeutic hypothermia is now widely offered to moderately or severely asphyxiated infants in high-income countries. The global burden of disease estimates indicate that perinatal asphyxia is a very significant problem in low and mid resourced settings. There are, however, several compelling reasons why the efficacy and safety data on therapeutic hypothermia from high-income countries cannot be extrapolated to neonatal units in transitional countries, such as India; in particular there is a lack of effective low tech servo controlled cooling equipments that can be used in these settings. This pilot phase II randomized control trial will examine the efficacy of phase changing material in providing satisfactory therapeutic hypothermia in neonatal encephalopathy, in a mid resource setting.

Conditions

Interventions

TypeNameDescription
PROCEDURECoolingReduction of rectal temperature to 33.5 C

Timeline

Start date
2009-07-01
Primary completion
2011-01-01
Completion
2011-08-01
First posted
2010-06-07
Last updated
2010-06-07

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01138176. Inclusion in this directory is not an endorsement.